logo

Aprea Therapeutics, Inc. (APRE)



Trade APRE now with
  Date
  Headline
9/18/2020 8:06:28 AM Aprea Therapeutics Promotes Gregory Wessels To Chief Commercial Officer
6/29/2020 7:30:10 AM Aprea Therapeutics Appoints Fouad Namouni And Richard Peters To Board
6/3/2020 8:15:27 AM Aprea Therapeutics Completes Full Enrollment Of Phase 3 Clinical Trial In TP53 MDS
5/15/2020 7:36:48 AM Aprea Therapeutics Q1 Net Loss $9.4 Mln Or $0.45/Shr Vs Loss Of $3.5 Mln Or $2.97/Shr Last Year
1/30/2020 7:49:45 AM Aprea Therapeutics Says FDA Granted Breakthrough Therapy Designation For APR-246